Skip to main content
Yixintang Pharmaceutical Group Co., Ltd. logo

Yixintang Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 002727 ISIN · CNE100001WJ8 LEI · 300300NE1YJT00E9JD69 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,825 across all filing types
Latest filing 2026-04-08 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002727

About Yixintang Pharmaceutical Group Co., Ltd.

https://www.hx8886.com

Yixintang Pharmaceutical Group Co., Ltd. operates an extensive network of retail pharmacies providing a broad spectrum of healthcare products and services. The company specializes in the distribution of Western pharmaceuticals, traditional Chinese medicine (TCM), medical equipment, and health supplements. Its operational model integrates physical storefronts with digital platforms to facilitate online-to-offline (O2O) services, including prescription fulfillment and health consultations. Key offerings include chronic disease management, professional pharmaceutical advice, and a diverse inventory of over-the-counter (OTC) medications. The company focuses on community-based health accessibility, utilizing a robust supply chain to ensure product quality and availability across its service regions.

Recent filings

Filing Released Lang Actions
关于控股子公司四川本草堂药业有限公司为下属子公司提供担保的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of guarantees provided by a controlling subsidiary to its own subsidiary. It details the guarantee amounts, the parties involved, financial indicators of the guaranteed company, and the necessity and rationality of the guarantee. There is no indication that this is a full financial report, audit report, or earnings release. The document is a formal announcement about financing-related guarantees and credit facilities, which fits the category of Capital/Financing Update (CAP). The document length is about 3,000 characters, which is consistent with an announcement rather than a full report. Therefore, the appropriate classification is CAP.
2026-04-08 Chinese
关于使用部分暂时闲置2018年公开发行可转换公司债券募集资金进行现金管理的进展公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company regarding the progress of using temporarily idle funds raised from a 2018 convertible bond issuance for cash management purposes. It details specific investments, contracts, risk analysis, and compliance with regulatory requirements. The document is structured as a formal announcement with tables of investment details and risk control measures, but it does not contain comprehensive financial statements or detailed financial performance data typical of an annual or interim report. It also does not fit categories like earnings release, management report, or capital update. The document is a regulatory announcement about the use of funds and cash management progress, which aligns with the category of Regulatory Filings (RNS).
2026-04-03 Chinese
关于使用部分暂时闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 一心堂药业集团股份有限公司 regarding the progress of using temporarily idle own funds for cash management. It details agreements with banks for structured deposits, investment risk analysis, risk control measures, and the impact on the company. The document includes tables of investment products, amounts, expected yields, and contract dates. It is a disclosure about financing activities related to cash management and investment of idle funds, not a full financial report or earnings release. It does not contain comprehensive financial statements or quarterly/yearly results. The document is not a report publication announcement since it contains substantive information about the cash management activities. Therefore, the document fits best under Capital/Financing Update (CAP).
2026-04-03 Chinese
关于全资子公司广西鸿翔一心堂药业有限责任公司向银行申请授信额度提供担保的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a guarantee provided by the parent company to its wholly-owned subsidiary for a bank credit facility. It includes details about the guarantee amount, the subsidiary's financial status, and the terms of the guarantee. The document is relatively short (2905 characters) and focuses on a specific financing guarantee event rather than presenting comprehensive financial statements or a full report. It does not contain quarterly or annual financial results, nor is it a transcript, management report, or legal proceeding update. The content fits best with a Capital/Financing Update as it relates to financing activities and guarantees provided by the company.
2026-03-26 Chinese
关于使用部分暂时闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about the progress of using temporarily idle funds for cash management, including details of investment products, contracts, risk analysis, and compliance with stock exchange regulations. It is not a full financial report but a specific update on cash management activities and related agreements. The document is about financing activities related to cash management and investment products, not an earnings release or annual report. Therefore, it fits best under Capital/Financing Update (CAP). The document length is sufficient and contains detailed information about financing activities, not just a brief announcement or certification.
2026-03-24 Chinese
关于控股子公司四川本草堂药业有限公司担保下属子公司绵阳本草堂药业有限公司向银行申请授信额度提供担保的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a guarantee provided by a controlling subsidiary for a bank credit application of its subordinate company. It includes details about the guarantee amount, the involved parties, financial indicators of the guaranteed company, and the necessity and rationality of the guarantee. The document is relatively short (2592 characters) and focuses on a specific financing guarantee event rather than comprehensive financial data or full financial statements. It does not contain quarterly or annual financial results, audit opinions, or management discussions. It is a regulatory announcement about a financing guarantee progress, which fits best under the category of Capital/Financing Update (CAP).
2026-03-24 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.